Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript
Source: SeekingAlpha
2026-03-25 19:15:57 ET
Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines March 19, 2026 10:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript
Viatris Inc.
NASDAQ: VTRS
VTRS Trading
-1.49% G/L:
$13.249 Last:
1,278,724 Volume:
$13.36 Open:
VTRS Latest News
March 23, 2026 06:59:00 am
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
March 19, 2026 08:30:00 am
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
VTRS Stock Data
$18,451,353,349
1,140,252,173
N/A
503
N/A
Pharmaceuticals
Healthcare
US
Canonsburg
